Source:http://linkedlifedata.com/resource/pubmed/id/14599119
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2003-11-5
|
pubmed:abstractText |
11beta-Hydroxysteroid dehydrogenase type 1 (11beta-HSD1) behaves predominantly as an oxoreductase converting the receptor-inactive glucocorticoids to their active forms in vivo, while the type 2 isoform (11beta-HSD2) possesses only dehydrogenase activity and inactivates cortisol in human or corticosterone in rat. We determined enzyme activity of 11beta-HSD in rat lungs from fetus to adult, and examined whether 11beta-HSD1 exists in alveolar type II cells, the most important site for the synthesis of pulmonary surfactant in mature lungs, by immunohistochemistry and reverse transcription-polymerase chain reaction (RT-PCR). Enzyme activity of 11beta-HSD1 and 2 in lung tissue homogenate were determined as NADP(+)- and NAD(+)-dependent conversion of corticosterone to 11-dehydrocorticosterone, respectively. We found that 11beta-HSD1 activity was increased progressively from 21 days gestation to 7 weeks after birth. 11beta-HSD2 activity was significantly lower than that of 11beta-HSD1 throughout gestation and after birth. Immunoreactivity for 11beta-HSD1 was detected in the cytoplasm of the cells in the alveolar region of adult rats. Some of these expressing 11beta-HSD1 were considered to be alveolar type II cells, because of their cuboid shape and localization at the corner of the alveoli. RT-PCR demonstrated 11beta-HSD1 mRNA in isolated alveolar type II cells. Our results suggest that alveolar type II cells enhance intracellular glucocorticoid availability via 11beta-HSD1. 11beta-HSD1 in alveolar type II cells is thought of as an autocrine amplifier of glucocorticoid action in the lung.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0918-8959
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
445-51
|
pubmed:meshHeading |
pubmed-meshheading:14599119-11-beta-Hydroxysteroid Dehydrogenase Type 1,
pubmed-meshheading:14599119-Aging,
pubmed-meshheading:14599119-Animals,
pubmed-meshheading:14599119-Epithelial Cells,
pubmed-meshheading:14599119-Fetus,
pubmed-meshheading:14599119-Gestational Age,
pubmed-meshheading:14599119-Immunohistochemistry,
pubmed-meshheading:14599119-Pulmonary Alveoli,
pubmed-meshheading:14599119-RNA, Messenger,
pubmed-meshheading:14599119-Rats,
pubmed-meshheading:14599119-Rats, Sprague-Dawley,
pubmed-meshheading:14599119-Reverse Transcriptase Polymerase Chain Reaction
|
pubmed:year |
2003
|
pubmed:articleTitle |
Expression of 11 beta-hydroxysteroid dehydrogenase type 1 in alveolar epithelial cells in rats.
|
pubmed:affiliation |
Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.
|
pubmed:publicationType |
Journal Article
|